Fine-tuning of T lymphocytes in autoimmunity: genetic association of CTLA-4 variants and Graves' disease revisited

被引：2

作者：

Badenhoop, K

Seidl, C

机构：

[1] Univ Hosp Frankfurt Main, Dept Med 1, Div Endocrinol, D-60590 Frankfurt, Germany

[2] Univ Hosp Frankfurt Main, Dept Immunohaematol, D-60590 Frankfurt, Germany

来源：

CLINICAL ENDOCRINOLOGY | 2003年 / 59卷 / 05期

关键词：

D O I：

10.1046/j.1365-2265.2003.01863.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：555 / 557

页数：3

共 20 条

[1] MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease [J].

Allahabadia, A ;

Heward, JM ;

Nithiyananthan, R ;

Gibson, SM ;

Reuser, TTQ ;

Dodson, PM ;

Franklyn, JA ;

Gough, SCL .

LANCET, 2001, 358 (9286) :984-985

[2] A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele [J].

Anjos, S ;

Nguyen, A ;

Ounissi-Benkalha, H ;

Tessier, MC ;

Polychronakos, C .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (48) :46478-46486

[3] Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations [J].

Bednarczuk, T ;

Hiromatsu, Y ;

Fukutani, T ;

Jazdzewski, K ;

Miskiewicz, P ;

Osikowska, M ;

Nauman, J .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (01) :13-18

[4] CTLA-4 and HLA gene susceptibility to thyroid-associated orbitopathy [J].

Buzzetti, R ;

Nisticò, L ;

Signore, A ;

Cascino, I .

LANCET, 1999, 354 (9192) :1824-1824

[5] CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression [J].

Carreno, BM ;

Bennett, F ;

Chau, TA ;

Ling, V ;

Luxenberg, D ;

Jussif, J ;

Baroja, ML ;

Madrenas, J .

JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1352-1356

[6] The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses [J].

Carreno, BM ;

Collins, M .

ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :29-53

[7] CTLA4 gene haplotypes cannot protect from IDDM in the presence of high-risk HLA DQ8 or DQ2 alleles in German families [J].

Donner, H ;

Seidl, C ;

Braun, J ;

Siegmund, T ;

Herwig, J ;

Seifried, E ;

Usadel, KH ;

Badenhoop, K .

DIABETES, 1998, 47 (07) :1158-1160

[8] The development of Graves' disease and the CTLA-4 gene on chromosome 2q33 [J].

Heward, JM ;

Allahabadia, A ;

Armitage, M ;

Hattersley, A ;

Dodson, PM ;

MacLeod, K ;

Carr-Smith, J ;

Daykin, J ;

Daly, A ;

Sheppard, MC ;

Holder, RL ;

Barnett, AH ;

Franklyn, JA ;

Gough, SCL .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (07) :2398-2401

[9] CTLA-4 gene polymorphisms in systemic lupus erythematosus:: a highly significant association with a determinant in the promoter region [J].

Hudson, LL ;

Rocca, K ;

Song, YW ;

Pandey, JP .

HUMAN GENETICS, 2002, 111 (4-5) :452-455

[10] Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene [J].

Kinjo, Y ;

Takasu, N ;

Komiya, I ;

Tomoyose, T ;

Takara, M ;

Kouki, T ;

Shimajiri, Y ;

Yabiku, K ;

Yoshimura, H .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06) :2593-2596

← 1 2 →